1.Validity and reliability of the Chinese parent proxy and child self-report health related quality of life measure for children with epilepsy (CHEQOL-25) in Malaysia
Su Woan Wo ; Pauline Siew Mei Lai ; Lai Choo Ong ; Wah Yun Low ; Kheng Seang Lim ; Chee Geap Tay ; Chee Piau Wong ; Ranjini Sivanesom
Neurology Asia 2016;21(3):235-245
Objective: To determine the validity and reliability of the Chinese parent proxy and child self-report
health related quality of life measure for children with epilepsy (CHEQOL-25) in Malaysia. Methods:
Face and content validity of the Chinese parent proxy and child self-report CHEQOL-25 was verified
by an expert panel, and piloted in five children with epilepsy (CWE). The Chinese CHEQOL-25 was
then administered to 40 parent proxies and their CWE (aged 8-18 years), from two tertiary hospitals,
at baseline and 2 weeks later. Results: Forty parents and their CWE were recruited. Cronbach’s alpha
for each subscale ranged from 0.56-0.83. At test-retest, the interclass correlation for all items ranged
from 0.68-0.97. Items 8 and 25 were removed as their corrected item-total correlation values were
<0.3. Epilepsy severity, the number of anti-epileptic drugs taken daily, number of close friends and
number of time spent with friends were found to be associated with the parent proxy CHEQOL-25
score. Duration of epilepsy, child’s cognitive ability, number of close friends and number of time spent
with friends were associated with child self-report CHEQOL-25. The parent proxy and the child selfreport
showed high to fair agreement on the “interpersonal/social” [Intraclass correlation coefficient
(ICC)=0.670, p<0.001] and “epilepsy secrecy” subscale (ICC=0.417, p=0.048).
Conclusions: Our small study found that the Chinese CHEQOL-25 was a valid and reliable questionnaire
to assess the quality of life of children with epilepsy from the parent prospective and child self-report
when items 8 and 25 were removed.
Epilepsy
2.Microvascular and macrovascular complications in young-onset type 2 diabetes in a tertiary health institution in Malaysia in comparison with type 1 diabetes patients.
Kim Piow Lim ; Siew Hui Foo ; Kean Yew Liew ; Kavitha Arumugam ; Nurafna Mohd Jaafar ; Yung Zhuang Choo ; Yen Shen Wong
Journal of the ASEAN Federation of Endocrine Societies 2016;31(2):125-130
OBJECTIVES: To compare the rate of diabetes complications in young-onset type 2 diabetes (T2DM) with type 1 diabetes (T1DM) patients and to examine the relationship between diabetes complications with clinical and metabolic parameters.
METHODOLOGY: This is a retrospective,comparative study based on electronic medical records review. Young-onset T2DM patients defined as those with disease onset before the age of 40 and T1DM patients were included. Data was collected on demographic and clinical parameters, cardiovascular risks factors, macrovascular and microvascular complications.
RESULTS: There were 194 young-onset T2DM and 45 T1DM subjects. Despite similar glycemic profile, more subjects in the T2DM group hadunfavourable cardiovascular risk factors and developedmacro- or microvascular complications than the T1DM group (22 vs. 0%, p< 0.001for macrovascular, 68 vs. 40%, p< 0.001 for microvascular). Afteradjustment ofthe confounders, young-onset T2DM remained an independent predictor for both macrovascular and microvascular complications in the overall cohort (HR= 2.635, p= 0.022).
CONCLUSION: Young-onset T2DM appeared to be a more aggressive disease compared to T1DM. An aggressive approach should be adopted in treating young-onset T2DM to optimise the cardiovascular risk factors and glycemic control to prevent premature mortality and morbidity.
Human ; Adult ; Diabetes Mellitus ; Patients ; Mortality ; Morbidity
3.Evaluation of a group family-based intervention programme for adolescent obesity: the LITE randomised controlled pilot trial.
Chu Shan Elaine CHEW ; Jean Yin OH ; Kumudhini RAJASEGARAN ; Seyed Ehsan SAFFARI ; Chee Ming Micheal LIM ; Siew Choo LIM ; Shiling TAN ; Siobhan KELLY
Singapore medical journal 2021;62(1):39-47
INTRODUCTION:
This study aimed to evaluate the LITE (Lifestyle Intervention for TEenagers) group programme, a family-based behavioural lifestyle intervention for overweight and obese adolescents.
METHODS:
We conducted a two-arm randomised controlled trial that recruited overweight and obese adolescents who attended a tertiary care weight management clinic. Participants were randomised to the LITE programme or usual care. The primary outcome assessed was body mass index (BMI) z-score. Secondary outcomes of anthropometric measurements, metabolic profile, parenting and adolescents' perception of family support were measured at baseline, three months and six months. Feasibility and acceptability of the LITE programme were also evaluated.
RESULTS:
61 adolescents were enrolled, with 31 in the LITE programme and 30 in usual care. At three months, participants in the programme had a greater reduction in weight (-0.18 ± 2.40 kg vs. 1.48 ± 1.97 kg; p = 0.107), waist circumference (-1.0 ± 3.1 cm vs. 2.4 ± 2.7 cm; p = 0.016), waist-height ratio (-0.01 ± 0.02 vs. 0.01 ± 0.02; p = 0.040) and systolic blood pressure (-3.8 ± 13.7 vs. 5.7 ± 13.1; p = 0.119) compared to the usual care group. There was no significant difference in BMI z-score. At six months, there were significant improvements in adolescents' perception of family support for eating habits in the LITE group compared to the usual care group. The LITE programme had a good attendance rate of 67.7% and was well received.
CONCLUSION
The LITE programme showed feasibility and short-term clinical effectiveness in improving some clinical outcomes and improved adolescents' perception of family support.